- Hair loss
- PTD-DBM + Valproic Acid in Thailand
Hair Loss · Medication Guide
PTD-DBM + Valproic Acid in Thailand
PTD-DBM is an experimental peptide, paired with topical valproic acid, that aims to switch on the Wnt pathway behind hair growth. Here is what the science actually shows, where the real risks sit, and how a doctor in Bangkok assesses whether it makes sense for you. Reviewed by a licensed physician at a MOPH-registered men's health clinic.
- Research compound · not a registered medicine
- Prescription · compounded case by case
/)
Medically reviewed by Dr. Juthathinin Piwpong
Menscape Clinic
Last reviewed
11 July 2026
2017
Peptide first described
in a published mouse hair-regrowth study
Mice
Main evidence base
no large controlled human trials to date
Wnt
Pathway both agents target
the signal that cycles hair follicles
0
Approvals for hair loss
not a registered medicine anywhere
Key takeaways
PTD-DBM is an experimental peptide combined with topical valproic acid; both aim to activate the Wnt/β-catenin pathway that controls hair follicle cycling, and neither is a registered hair-loss medicine in Thailand or anywhere else.
The evidence is early: PTD-DBM's hair-regrowth data comes from animal studies, and valproic acid has only small human pilots, so no honest doctor can promise a result.
Valproic acid is a known teratogen, so anyone who is or could become pregnant must not handle it, and that risk shapes who can use this compound and how.
It is prescription-only and compounded case by case; a doctor decides if it is reasonable for you, usually after the evidence-backed options of finasteride and minoxidil.
01
What it is & how it works
PTD-DBM is an experimental peptide studied for male-pattern hair loss (androgenetic alopecia). Valproic acid is an established prescription medicine for epilepsy and mood disorders that is being explored off-label, applied to the scalp, for the same purpose. Menscape formulates them together as a compounded topical. It is not a finished, approved product.
Both act on the same target. Hair follicles cycle between growth and rest under a signal called Wnt/β-catenin. In balding scalp, that signal is held down. PTD-DBM binds a protein called Dishevelled and blocks CXXC5, a natural brake on Wnt. Valproic acid inhibits the enzyme GSK-3β, which stabilises β-catenin. In theory, releasing both brakes nudges follicles back toward the growth phase.
That is the hypothesis, not a proven regimen. Human evidence is thin, and the level of proof is well below finasteride and minoxidil. First-line, evidence-backed treatments come first. A doctor's job is to weigh whether an experimental option is reasonable for you at all.
Be clear about the label. PTD-DBM is a research compound, not a registered medicine in Thailand, and valproic acid is licensed here only for epilepsy and mood disorders. Using the two together for hair is off-label and unproven, which is why it sits behind a doctor rather than on a shelf.
Wnt keeps follicles cycling
The Wnt/β-catenin signal tells follicles to enter and hold the growth (anagen) phase.
CXXC5 and GSK-3β are brakes
These proteins damp the Wnt signal, and in genetically sensitive scalp that brake stays on.
PTD-DBM releases one brake
The peptide binds Dishevelled and blocks CXXC5, so Wnt signalling is less suppressed.¹
Valproic acid releases another
It inhibits GSK-3β, stabilising β-catenin; in theory follicles then re-enter growth.²
02
Getting PTD-DBM + valproic acid in Thailand
Thai FDA status
PTD-DBM is not registered as a medicine with the Thai FDA, or any regulator, because it is a research compound. Valproic acid is Thai FDA registered, but for epilepsy and bipolar disorder, sold under brands such as Depakine. Using it on the scalp for hair is off-label. Neither is an approved hair-loss product.
How Menscape handles it
Only after a doctor's assessment, and only prepared by a licensed compounding pharmacy against a prescription. It is not an off-the-shelf item and not something you can order online. If a doctor judges it unreasonable for you, it is not dispensed.
Why the grey market is risky
"Research chemical" PTD-DBM powders sold online are unregulated, often mislabelled, and of unknown purity or sterility. Self-mixing valproic acid at home is dangerous: it is a teratogen with real dosing hazards. There is no accountability for what arrives in the post.
Regulatory note. Valproic acid is a prescription-controlled medicine; PTD-DBM holds no marketing authorisation as a drug. The Thai FDA has repeatedly warned against buying medicines from unlicensed online sellers, where counterfeits are common.⁶
03
Does it work? The evidence
The encouraging results for PTD-DBM come from mouse studies. A 2017 paper showed that targeting CXXC5 with this competing peptide stimulated hair regrowth and wound-induced hair neogenesis in animal models. There are no published large, randomised human trials. Valproic acid has small human pilot studies in men with androgenetic alopecia, with some reporting a modest rise in hair count, but the studies are small and the results are inconsistent.
So the mechanism is plausible and the early signals are interesting, but the level of proof sits far below finasteride and minoxidil. Nobody can promise regrowth from this compound. If you try it, treat it as experimental, do so under medical supervision, and keep your expectations measured against the evidence-backed options.
Put plainly, this is early-stage science. The mouse work is promising and the human valproic acid pilots are suggestive, but neither clears the bar of a large randomised human trial. Anyone weighing it should read that gap honestly and judge it against treatments that already have decades of human data.
Mice
PTD-DBM evidence
regrowth shown in animal models, not human trials
Pilot
Valproic acid evidence
small human studies, mixed results
Based on preclinical (mouse) work targeting CXXC5 and small human pilot studies of topical valproic acid. No large randomised trials exist, and individual results are unpredictable.¹²³
04
Side effects & who shouldn't take it
Common, local effects
As with most scalp topicals, the likely effects are at the application site: irritation, redness, itching, dryness or flaking. These are usually mild and settle when use stops, but tell your doctor if they persist.
The valproic acid concern
Valproic acid is a proven teratogen, linked to neural tube defects and developmental harm. Even applied to the scalp, some systemic absorption is possible. At systemic levels it can also affect the liver and platelets. This is the defining risk of the compound.⁴
Not suitable for
Anyone who is or could become pregnant must not use or handle it, and a pregnant partner must not touch the treated scalp or the product. Caution is needed with liver disease. It is not a treatment for women of childbearing potential.⁵
Interactions & unknowns
Systemically absorbed valproate can interact with other anticonvulsants such as lamotrigine and with blood thinners such as warfarin. Its long-term safety for hair loss in humans is simply not established. Tell your doctor everything you take.
05
Alternatives & combinations
Oral · first-line evidence
Finasteride
The most-studied oral treatment for male-pattern hair loss. It lowers scalp DHT and is proven in large trials, which is why it is usually tried before any experimental option.
Topical · first-line
Minoxidil
A topical solution or foam that stimulates follicles directly, with strong evidence and regulatory approval. Often the baseline treatment, alone or alongside finasteride.
Compounded · combination
Topical finasteride + minoxidil
A compounded combination with far more human data than PTD-DBM. A doctor may prefer it when you want a topical route with a real evidence base behind it.
06
How prescription works at Menscape
/)
Book your hair consultation today.
Message us on WhatsApp or LINE
Five minutes on your phone: photos, health history, current medications. It is free and PDPA-protected.
Doctor consultation
A licensed Thai physician reviews your case by video or in clinic at Asoke, explains where the evidence stands, and weighs an experimental compound against first-line options.
Compounded prescription, if suitable
If the doctor judges it reasonable, the topical is prepared by a licensed compounding pharmacy against your prescription, for pickup or delivery.
Follow-up & monitoring
Progress photos and check-ins over the following months. If there is no benefit or the scalp reacts, the plan is stopped and reassessed against proven treatments.
The doctor decides. An assessment is not a purchase and does not guarantee a prescription. For most men, evidence-backed treatments come first; an experimental compound is only considered when it genuinely makes sense for you.
Medically reviewed by
Dr. Juthathinin Piwpong
Menscape Clinic, Bangkok
“PTD-DBM is genuinely interesting science, but interesting is not the same as proven. I start every patient on the treatments we have real evidence for, and only consider an experimental compound with clear eyes and close monitoring.”
- Reviewed
- 11 July 2026
- Next review
- January 2027
- Editorial standard
- Each guide is checked against the Thai FDA label and the primary literature, then reviewed by a licensed physician.
07
Frequently asked questions
Can I buy PTD-DBM over the counter in Thailand?
No. PTD-DBM is not a registered medicine anywhere, so there is no legitimate over-the-counter version, and valproic acid is prescription-only. The "research chemical" powders sold online are unregulated and carry real purity and safety risks.
Does PTD-DBM actually regrow hair?
The encouraging data is from mouse studies, and there are no large human trials. Some men may respond, but nobody can promise it. It is best treated as an experimental option, not a proven one.
Is it safe?
The main concern is valproic acid, a known teratogen, and scalp irritation is the common local effect. Long-term human safety for hair loss is not established, which is exactly why it should only be used under a doctor's supervision.
Why is valproic acid, an epilepsy drug, used for hair?
It is off-label. Valproic acid inhibits GSK-3β and helps activate the Wnt pathway that drives hair growth, which is why it has been studied topically. It is not approved for hair loss.
Should I use this instead of finasteride or minoxidil?
Usually not first. Finasteride and minoxidil have far stronger evidence. An experimental compound like this is only considered after, or alongside, proven options, and always under a doctor.
Can I order PTD-DBM powder and mix it myself?
No. The purity and sterility of online powders are unknown, and mixing valproic acid at home is dangerous. It must be compounded by a licensed pharmacy against a prescription.
My partner is pregnant. Is this safe to use at home?
Be very careful. Valproic acid is teratogenic, so a pregnant person must never handle the product or touch the treated scalp. Discuss this with your doctor before using it at home.
I already use a topical hair compound from abroad. Can Menscape review it?
Yes. Bring the formula and your medical history, and a doctor can review whether it is appropriate and safe to continue, adjust, or replace with a better-evidenced option.
08
References
1. Lee S, et al. Targeting of CXXC5 by a competing peptide stimulates hair regrowth and wound-induced hair neogenesis. J Invest Dermatol. 2017;137(11):2260-2269.
2. Lee SH, et al. Valproic acid induces hair regeneration in murine models and activates alkaline phosphatase activity in human dermal papilla cells. PLoS One. 2012;7(4):e34152.
3. Jo SJ, et al. Topical valproic acid increases the hair count in men with androgenetic alopecia: a feasibility study. J Dermatol. 2014.
4. U.S. FDA. Valproate products prescribing information — boxed warnings on teratogenicity and hepatotoxicity. Accessed July 2026.
5. European Medicines Agency. Valproate and related substances: pregnancy prevention programme. 2018.
6. Thai Food and Drug Administration — drug registration database, ndi.fda.moph.go.th. Accessed July 2026.
This guide is educational information, not medical advice. PTD-DBM with valproic acid is an experimental, compounded prescription treatment that is not approved for hair loss and must be assessed and monitored by a licensed physician.
This guide is part of the Menscape hair-loss library
Explore the condition hubTempted by an experimental hair compound online? Ask a doctor, not a forum.
/)